RxDoctor Payments Data

Justin Kirby

Nurse Practitioner · Chattanooga, TNNPI 1104364496

Payments from drug & device makers

$3,624in general payments, 2019–2025

Across 192 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$452
  • United Therapeutics Corporation$340
  • Lilly USA, LLC$300
  • Sanofi$206
  • AstraZeneca$199
  • Actelion Pharmaceuticals US, Inc.$173
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$3,59299%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,624 in reported general payments places this provider in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$11,208
Medicare patients
87
Services billed
140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter201$238,140
Dupixent SyringeDupilumab12$46,291
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$40,589
Breo ElliptaFluticasone/Vilanterol28$17,780
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr35$15,828
Spiriva RespimatTiotropium Bromide12$11,185
SymbicortBudesonide/Formoterol Fumarate21$9,169
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$6,771
Albuterol Sulfate HfaAlbuterol Sulfate139$6,043
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$3,826
Azithromycin27$480
Montelukast Sodium39$416
Fluticasone Propionate16$322
Prednisone29$187
Methylprednisolone11$83

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$452$271,748264 claims
AstraZenecaBreztri Aerosphere, Symbicort$199$49,75852 claims
Boehringer IngelheimSpiriva Respimat$109$11,18512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →